Paper9720548
Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability?
Michel MC and 5 others. J Urol, 1998. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? Papers, record 9720548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9720548
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability?
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Hypertension | Major topic |
| Prostatic Hyperplasia | Major topic |
| Sulfonamides | Major topic |
| Drug Tolerance | |
| Humans | |
| Male | |
| Middle Aged | |
| Tamsulosin |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40338280 | Characteristics of men using non-prescription medicines to treat their lower urinary tract symptoms. | World J Urol | 2025 | https://conductscience.org/library/papers/40338280 | PubMed |
| 37289405 | A systematic review and meta-analysis of efficacy and safety comparing greenlight laser vaporization with transurethral resection of the prostate for benign prostatic hyperplasia with prostate volume less than 80 ml. | Lasers Med Sci | 2023 | https://conductscience.org/library/papers/37289405 | PubMed |
| 37063295 | Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patients. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37063295 | PubMed |
| 34729233 | The impact of preoperative lower urinary tract symptoms medication on the functional performance of holmium laser enucleation of the prostate. | Cent European J Urol | 2021 | https://conductscience.org/library/papers/34729233 | PubMed |
| 33941632 | Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial. | BMJ Open | 2021 | https://conductscience.org/library/papers/33941632 | PubMed |
| 32880664 | [Management of geriatric patients with benign prostatic hyperplasia]. | Urologe A | 2020 | https://conductscience.org/library/papers/32880664 | PubMed |
| 32581791 | Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32581791 | PubMed |
| 32104330 | Preparation and stability investigation of tamsulosin hydrochloride sustained release pellets containing acrylic resin polymers with two different techniques. | Asian J Pharm Sci | 2017 | https://conductscience.org/library/papers/32104330 | PubMed |
| 29492398 | Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial. | Res Rep Urol | 2018 | https://conductscience.org/library/papers/29492398 | PubMed |
| 25903582 | Is absorption of irrigation fluid a problem in Thulium laser vaporization of the prostate? A prospective investigation using the expired breath ethanol test. | BMC Urol | 2015 | https://conductscience.org/library/papers/25903582 | PubMed |
| 25834406 | Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/25834406 | PubMed |
| 25425136 | Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial. | BMC Urol | 2014 | https://conductscience.org/library/papers/25425136 | PubMed |
| 23370938 | Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. | Eur Radiol | 2013 | https://conductscience.org/library/papers/23370938 | PubMed |
| 21745239 | Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21745239 | PubMed |
| 21496064 | Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin. | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21496064 | PubMed |
| 20170206 | Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations. | Clin Pharmacokinet | 2010 | https://conductscience.org/library/papers/20170206 | PubMed |
| 19570487 | Diabetes and benign prostatic hyperplasia: emerging clinical connections. | Curr Urol Rep | 2009 | https://conductscience.org/library/papers/19570487 | PubMed |
| 17953457 | Pharmacological management of renal colic in the older patient. | Drugs Aging | 2007 | https://conductscience.org/library/papers/17953457 | PubMed |
| 17906864 | Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. | World J Urol | 2007 | https://conductscience.org/library/papers/17906864 | PubMed |
| 16986051 | A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. | Rev Urol | 2005 | https://conductscience.org/library/papers/16986051 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9720548
GET https://conductscience.org/api/papers/v1/9720548/cited_by?page=2